Inez Wens

Diepenbeek, VLG 3590, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Liver X receptors: A therapeutic target in demyelinating disorders.

Liver X receptors: A therapeutic target in demyelinating disorders.

Journal: Pharmacological research

Published: May 26, 2025

Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple Sclerosis.

Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple Sclerosis.

Journal: European journal of neurology

Published: April 11, 2025

AAV-Based Intracerebral Administration of BDNF Promotes Myelin Repair and Cognitive Improvement After Cuprizone-Induced Demyelination.

AAV-Based Intracerebral Administration of BDNF Promotes Myelin Repair and Cognitive Improvement After Cuprizone-Induced Demyelination.

Journal: Glia

Published: December 25, 2024

Early Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice.

Early Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice.

Journal: Cells

Published: March 13, 2024

The Efficiency of Brain-Derived Neurotrophic Factor Secretion by mRNA-Electroporated Regulatory T Cells Is Highly Impacted by Their Activation Status.

The Efficiency of Brain-Derived Neurotrophic Factor Secretion by mRNA-Electroporated Regulatory T Cells Is Highly Impacted by Their Activation Status.

Journal: European journal of immunology

Published: February 29, 2024

Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives.

Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives.

Journal: International journal of molecular sciences

Published: September 21, 2022

Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis.

Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis.

Journal: Biomolecules

Published: January 10, 2022

Engineering of regulatory T cells by means of mRNA electroporation in a GMP-compliant manner.

Engineering of regulatory T cells by means of mRNA electroporation in a GMP-compliant manner.

Journal: Cytotherapy

Published: August 20, 2021

Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies.

Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies.

Journal: International journal of molecular sciences

Published: May 31, 2021

Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD.

Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD.

Journal: International journal of molecular sciences

Published: May 31, 2021

Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and meta-analysis of clinical trials.

Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and meta-analysis of clinical trials.

Journal: Autoimmunity reviews

Published: March 31, 2021

Impact of Exercise-Nutritional State Interactions in Patients with Type 2 Diabetes.

Impact of Exercise-Nutritional State Interactions in Patients with Type 2 Diabetes.

Journal: Medicine and science in sports and exercise

Published: October 26, 2019

Showing 1-12 of 54

Last Updated: 09/26/2026